封面
市場調查報告書
商品編碼
1619340

甲狀腺功能測試市場規模、佔有率和成長分析(按類型、最終用戶和地區):產業預測(2024-2031)

Thyroid Function Test Market Size, Share, Growth Analysis, By Type (TSH Tests, T4 Tests), By End User (Hospitals, Diagnostic Laboratories), By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球甲狀腺功能檢測市場規模為11億美元,從2023年的12億美元成長到2031年的24.5億美元,預計複合年成長率為9.3%。

由於格雷夫茲病和橋本甲狀腺炎等甲狀腺疾病的盛行率不斷增加,甲狀腺功能檢測市場預計將顯著成長。由於老年人口的不斷增加和甲狀腺健康意識的增強,對這些血液檢測的需求預計將激增。實驗室(包括醫院和實驗室)嚴重依賴這些測試,這些測試測量重要的荷爾蒙水平,如 TSH、T4、T3 和游離4碘甲狀腺素。久坐的生活方式、過量飲酒以及自體免疫疾病和糖尿病發病率上升等因素進一步推動了市場擴張。此外,主要產業參與者之間開發創新檢測方法的策略聯盟將支持成長。總體而言,美國甲狀腺功能檢測市場預計未來幾年將維持強勁的複合年成長率。

目錄

介紹

  • 分析目的
  • 市場範圍
  • 定義

分析方法

  • 資訊採購
  • 次要/主要資料方法
  • 市場規模預測
  • 市場假設與約束

執行摘要

  • 市場概況及展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及前景

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特的分析

主要市場考慮因素

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場魅力指數(2023)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析

全球甲狀腺功能測試市場規模和複合年成長率:按類型(2024-2031)

  • 市場概況
  • 促甲狀腺激素測試
  • T4測試
  • T3測試
  • 其他測試

全球甲狀腺功能測試市場規模和複合年成長率:按最終用戶分類(2024-2031)

  • 市場概況
  • 醫院
  • 診斷實驗室
  • 檢驗室/實驗室
  • 其他最終用戶

全球甲狀腺功能檢測市場規模/複合年成長率(2024-2031)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要企業採取的策略
  • 近期市場趨勢
  • 主要企業市場佔有率(2023年)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • 賽默飛世爾科技(美國)
  • 雅培實驗室(美國)
  • 羅氏診斷(瑞士)
  • 丹納赫公司(美國)
  • 迪亞索林(義大利)
  • 西門子醫療(德國)
  • 默克公司(德國)
  • Bio-Rad 實驗室(美國)
  • Ortho 臨床診斷(美國)
  • 貝克曼庫爾特(美國)
  • F. Hoffmann-La Roche Ltd.(瑞士)
  • 奎德爾奧索(美國)
  • 伊諾瓦診斷公司(美國)
  • 積水診斷(美國)
  • Trinity Biotech(愛爾蘭)
  • ARUP實驗室(美國)
  • 奎斯特診斷(美國)
  • 美國實驗室控股公司(美國)
  • Eurofins Scientific(盧森堡)
  • MSD(默克公司)(美國)

結論和建議

簡介目錄
Product Code: SQMIG35E2010

Global Thyroid Function Test Market size was valued at USD 1.1 billion in 2022 and is poised to grow from USD 1.2 billion in 2023 to USD 2.45 billion by 2031, growing at a CAGR of 9.3% during the forecast period (2024-2031).

The Thyroid Function Test market is poised for significant growth, driven by an increasing prevalence of thyroid disorders such as Graves' disease and Hashimoto's thyroiditis. With a rising geriatric population and heightened awareness of thyroid health, demand for these blood tests is anticipated to surge. Healthcare sectors, including hospitals and research laboratories, rely heavily on these tests, which measure vital hormone levels like TSH, T4, T3, and free T4. Contributing factors such as sedentary lifestyles, excessive alcohol consumption, and the rise of autoimmune disorders and diabetes further underpin market expansion. Additionally, strategic collaborations among key industry players aimed at developing innovative detection methods will bolster growth. Overall, the U.S. Thyroid Function Test market is projected to sustain a robust CAGR in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Thyroid Function Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Thyroid Function Test Market Segmental Analysis

Global Thyroid Function Test Market is segmented by type, end user and region. Based on type, the market is segmented into TSH tests, t4 tests, t3 tests and other tests. Based on end user, the market is segmented into hospitals, diagnostic laboratories, research laboratories & institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Thyroid Function Test Market

The global market for thyroid function tests is anticipated to experience significant growth due to the rising incidence of thyroid cancers coupled with the pressing demand for affordable diagnostic solutions. As more individuals seek effective screening methods for thyroid disorders, the market is further propelled by increased government funding aimed at enhancing healthcare infrastructure in both developed and emerging countries. Additionally, the swift evolution of lifestyle factors contributing to thyroid health emphasizes the critical need for such tests. Collectively, these factors are set to stimulate advancements and expansions within the thyroid function test market throughout the forecast period.

Restraints in the Global Thyroid Function Test Market

The Global Thyroid Function Test (GTFT) is a comprehensive assessment that evaluates the hormonal activity and regulatory mechanisms of the thyroid gland through a singular, integrative approach. Its primary restraint lies in the potential for false positives or negatives, influenced by individual variations in thyroid hormone metabolism, concurrent illnesses, or medications that may interfere with thyroid function. Additionally, GTFT may not specifically identify the nuances of certain thyroid disorders, leading to misinterpretation of results. Consequently, it should be interpreted in conjunction with clinical evaluations and additional diagnostic tests to ensure accurate assessment and effective management of thyroid-related conditions.

Market Trends of the Global Thyroid Function Test Market

The global thyroid function test market is witnessing a significant trend towards point-of-care testing, driven by the demand for convenience and faster results. This shift allows for immediate diagnosis and ongoing monitoring of thyroid disorders, enhancing patient management and treatment outcomes. By enabling tests to be conducted outside traditional laboratory settings, point-of-care testing reduces the waiting period for results, thus improving accessibility for patients. As healthcare providers prioritize efficient diagnostic solutions, the adoption of portable, user-friendly devices is expected to rise, further propelling market growth. This trend reflects a broader movement towards personalized medicine and streamlined healthcare delivery.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Thyroid Function Test Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • TSH Tests
  • T4 Tests
  • T3 Tests
  • Other Tests

Global Thyroid Function Test Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories & Institutes
  • Other End Users

Global Thyroid Function Test Market Size & CAGR (2024-2031)

  • North America (Type, End User)
    • US
    • Canada
  • Europe (Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Thermo Fisher Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ortho Clinical Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QuidelOrtho (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inova Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sekisui Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinity Biotech (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARUP Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MSD (Merck & Co.) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations